Published in J Clin Invest on November 12, 2012
Angelman syndrome: review of clinical and molecular aspects. Appl Clin Genet (2014) 1.14
Allelic specificity of Ube3a expression in the mouse brain during postnatal development. J Comp Neurol (2014) 1.07
Electrochemical Analysis of Neurotransmitters. Annu Rev Anal Chem (Palo Alto Calif) (2015) 1.01
Angelman Syndrome. Neurotherapeutics (2015) 0.90
In vivo amphetamine action is contingent on αCaMKII. Neuropsychopharmacology (2014) 0.88
Seizure-like activity in a juvenile Angelman syndrome mouse model is attenuated by reducing Arc expression. Proc Natl Acad Sci U S A (2015) 0.84
Loss of UBE3A from TH-expressing neurons suppresses GABA co-release and enhances VTA-NAc optical self-stimulation. Nat Commun (2016) 0.82
Dissociation of locomotor and cerebellar deficits in a murine Angelman syndrome model. J Clin Invest (2015) 0.79
New Perspectives on Genomic Imprinting, an Essential and Multifaceted Mode of Epigenetic Control in the Developing and Adult Brain. Annu Rev Neurosci (2016) 0.78
Dopamine D2/3 receptor antagonism reduces activity-based anorexia. Transl Psychiatry (2015) 0.78
Changes in sensitivity of reward and motor behavior to dopaminergic, glutamatergic, and cholinergic drugs in a mouse model of fragile X syndrome. PLoS One (2013) 0.78
Different contributions of dopamine D1 and D2 receptor activity to alcohol potentiation of brain stimulation reward in C57BL/6J and DBA/2J mice. J Pharmacol Exp Ther (2014) 0.78
Potential therapeutic approaches for Angelman syndrome. Expert Opin Ther Targets (2015) 0.77
Convergent synaptic and circuit substrates underlying autism genetic risks. Front Biol (Beijing) (2014) 0.77
Autism gene Ube3a and seizures impair sociability by repressing VTA Cbln1. Nature (2017) 0.76
Effects of the neuroactive steroid allopregnanolone on intracranial self-stimulation in C57BL/6J mice. Psychopharmacology (Berl) (2014) 0.76
Of mothers and myelin: Aberrant myelination phenotypes in mouse model of Angelman syndrome are dependent on maternal and dietary influences. Behav Brain Res (2015) 0.76
Pharmacological therapies for Angelman syndrome. Wien Med Wochenschr (2016) 0.76
From Cortical and Subcortical Grey Matter Abnormalities to Neurobehavioral Phenotype of Angelman Syndrome: A Voxel-Based Morphometry Study. PLoS One (2016) 0.75
Cellular and Circuitry Bases of Autism: Lessons Learned from the Temporospatial Manipulation of Autism Genes in the Brain. Neurosci Bull (2017) 0.75
The efficiency of systematic sampling in stereology and its prediction. J Microsc (1987) 10.24
UBE3A/E6-AP mutations cause Angelman syndrome. Nat Genet (1997) 5.97
Stereological methods for estimating the total number of neurons and synapses: issues of precision and bias. Trends Neurosci (1999) 5.15
Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. Proc Natl Acad Sci U S A (2000) 4.83
Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis. Neuron (2010) 4.76
Brain dopamine and reward. Annu Rev Psychol (1989) 4.41
An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin. Cell (2001) 4.41
Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons. J Biol Chem (2003) 4.36
Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease. Science (2001) 4.18
Brain reward circuitry: insights from unsensed incentives. Neuron (2002) 3.98
Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice. Proc Natl Acad Sci U S A (2007) 3.50
Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1. Neuron (2005) 3.30
Angelman and Prader-Willi syndromes share a common chromosome 15 deletion but differ in parental origin of the deletion. Am J Med Genet (1989) 3.22
Parkin, PINK1, and DJ-1 form a ubiquitin E3 ligase complex promoting unfolded protein degradation. J Clin Invest (2009) 3.17
Overoxidation of carbon-fiber microelectrodes enhances dopamine adsorption and increases sensitivity. Analyst (2003) 3.04
Angelman syndrome 2005: updated consensus for diagnostic criteria. Am J Med Genet A (2006) 2.86
The Angelman syndrome candidate gene, UBE3A/E6-AP, is imprinted in brain. Nat Genet (1997) 2.77
Multifaceted roles of beta-arrestins in the regulation of seven-membrane-spanning receptor trafficking and signalling. Biochem J (2003) 2.42
Parkin disease: a phenotypic study of a large case series. Brain (2003) 2.41
Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse. Hum Mol Genet (2003) 2.26
Maternal origin of 15q11-13 deletions in Angelman syndrome suggests a role for genomic imprinting. Am J Med Genet (1990) 2.11
Accumulation of the authentic parkin substrate aminoacyl-tRNA synthetase cofactor, p38/JTV-1, leads to catecholaminergic cell death. J Neurosci (2005) 2.06
Microelectrodes for the measurement of catecholamines in biological systems. Anal Chem (1996) 2.00
Imprinting of the Angelman syndrome gene, UBE3A, is restricted to brain. Nat Genet (1997) 1.92
Aggregated and monomeric alpha-synuclein bind to the S6' proteasomal protein and inhibit proteasomal function. J Biol Chem (2003) 1.91
Cocaine supersensitivity and enhanced motivation for reward in mice lacking dopamine D2 autoreceptors. Nat Neurosci (2011) 1.89
The ubiquitin-proteasome pathway in Parkinson's disease and other neurodegenerative diseases. Trends Cell Biol (2004) 1.76
Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis. Hum Mol Genet (2001) 1.74
Angelman syndrome: insights into genomic imprinting and neurodevelopmental phenotypes. Trends Neurosci (2011) 1.72
Parkinson phenotype in aged PINK1-deficient mice is accompanied by progressive mitochondrial dysfunction in absence of neurodegeneration. PLoS One (2009) 1.71
Clinical and subclinical dopaminergic dysfunction in PARK6-linked parkinsonism: an 18F-dopa PET study. Ann Neurol (2002) 1.51
Changes in extracellular dopamine induced by morphine and cocaine: crucial control by D2 receptors. J Neurosci (2002) 1.50
Autism in Angelman syndrome: implications for autism research. Clin Genet (2004) 1.37
Role of ubiquitination in endocytic trafficking of G-protein-coupled receptors. Traffic (2010) 1.35
Autism in Angelman syndrome: a population-based study. Pediatr Neurol (1996) 1.34
The E6-Ap ubiquitin-protein ligase (UBE3A) gene is localized within a narrowed Angelman syndrome critical region. Genome Res (1997) 1.34
Human DJ-1 and its homologs are novel glyoxalases. Hum Mol Genet (2012) 1.33
A comparison of model-based (2D) and design-based (3D) stereological methods for estimating cell number in the substantia nigra pars compacta (SNpc) of the C57BL/6J mouse. Neuroscience (2009) 1.26
SEPT5_v2 is a parkin-binding protein. Brain Res Mol Brain Res (2003) 1.17
Striatal and cortical pre- and postsynaptic dopaminergic dysfunction in sporadic parkin-linked parkinsonism. Brain (2004) 1.16
Absence of dopamine D2 receptors unmasks an inhibitory control over the brain circuitries activated by cocaine. Proc Natl Acad Sci U S A (2007) 1.15
Pharmacokinetics of systemically administered cocaine and locomotor stimulation in mice. J Pharmacol Exp Ther (1987) 1.14
Differential effects of dopaminergic therapies on dorsal and ventral striatum in Parkinson's disease: implications for cognitive function. Parkinsons Dis (2011) 1.13
Cocaine-induced locomotor activity and cocaine discrimination in dopamine D2 receptor mutant mice. Psychopharmacology (Berl) (2002) 1.10
Application of high performance liquid chromatography with electrochemical detection to neurochemical analysis: measurement of catecholamines, serotonin and metabolites in rat brain. J Neurosci Methods (1981) 1.09
The ubiquitin ligase E6-AP promotes degradation of alpha-synuclein. J Neurochem (2009) 1.01
Alcohol, cocaine, and brain stimulation-reward in C57Bl6/J and DBA2/J mice. Alcohol Clin Exp Res (2009) 1.01
Ventral tegmental area dopamine neurons are resistant to human mutant alpha-synuclein overexpression. Neurobiol Dis (2006) 1.00
Clinical features and neuroimaging of PARK7-linked parkinsonism. Mov Disord (2003) 0.98
Loss of dopaminergic neurons and resulting behavioural deficits in mouse model of Angelman syndrome. Neurobiol Dis (2010) 0.98
Normal social seeking behavior, hypoactivity and reduced exploratory range in a mouse model of Angelman syndrome. BMC Genet (2011) 0.98
Pael-R transgenic mice crossed with parkin deficient mice displayed progressive and selective catecholaminergic neuronal loss. J Neurochem (2008) 0.94
Epilepsy in Angelman syndrome. Seizure (2007) 0.92
Brain stimulation and morphine reward deficits in dopamine D2 receptor-deficient mice. Psychopharmacology (Berl) (2005) 0.90
Sensory processing patterns in persons with Angelman syndrome. Am J Occup Ther (2006) 0.90
Drosophila Ube3a regulates monoamine synthesis by increasing GTP cyclohydrolase I activity via a non-ubiquitin ligase mechanism. Neurobiol Dis (2010) 0.88
Levodopa responsive Parkinsonism in adults with Angelman Syndrome. J Clin Neurosci (2001) 0.83
Angelman syndrome: advancing the research frontier of neurodevelopmental disorders. J Neurodev Disord (2010) 0.79
A role for dopamine in the psychopharmacology of electrical self-stimulation. Natl Inst Drug Abuse Res Monogr Ser (1975) 0.79
Subsecond dopamine release promotes cocaine seeking. Nature (2003) 6.53
Associative learning mediates dynamic shifts in dopamine signaling in the nucleus accumbens. Nat Neurosci (2007) 4.97
NMDA receptor-dependent ocular dominance plasticity in adult visual cortex. Neuron (2003) 3.79
Dopamine operates as a subsecond modulator of food seeking. J Neurosci (2004) 3.79
Real-time measurement of dopamine fluctuations after cocaine in the brain of behaving rats. Proc Natl Acad Sci U S A (2005) 3.49
Regulation of NMDA receptor subunit expression and its implications for LTD, LTP, and metaplasticity. Neuropharmacology (2008) 3.30
Topoisomerase inhibitors unsilence the dormant allele of Ube3a in neurons. Nature (2011) 3.19
Resolving neurotransmitters detected by fast-scan cyclic voltammetry. Anal Chem (2004) 3.18
Overoxidation of carbon-fiber microelectrodes enhances dopamine adsorption and increases sensitivity. Analyst (2003) 3.04
Real-time chemical responses in the nucleus accumbens differentiate rewarding and aversive stimuli. Nat Neurosci (2008) 2.76
Detecting subsecond dopamine release with fast-scan cyclic voltammetry in vivo. Clin Chem (2003) 2.58
Monitoring rapid chemical communication in the brain. Chem Rev (2008) 2.48
Conditional knock-out of Kir4.1 leads to glial membrane depolarization, inhibition of potassium and glutamate uptake, and enhanced short-term synaptic potentiation. J Neurosci (2007) 2.44
Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3. Hum Mol Genet (2011) 2.38
Ube3a is required for experience-dependent maturation of the neocortex. Nat Neurosci (2009) 2.28
Regional specificity in the real-time development of phasic dopamine transmission patterns during acquisition of a cue-cocaine association in rats. Eur J Neurosci (2009) 2.22
Synaptic overflow of dopamine in the nucleus accumbens arises from neuronal activity in the ventral tegmental area. J Neurosci (2009) 2.16
Rapid dopamine signaling in the nucleus accumbens during contingent and noncontingent cocaine administration. Neuropsychopharmacology (2005) 2.14
Cannabinoids enhance subsecond dopamine release in the nucleus accumbens of awake rats. J Neurosci (2004) 2.10
Preferential enhancement of dopamine transmission within the nucleus accumbens shell by cocaine is attributable to a direct increase in phasic dopamine release events. J Neurosci (2008) 1.97
Phasic nucleus accumbens dopamine encodes risk-based decision-making behavior. Biol Psychiatry (2011) 1.96
Real-time decoding of dopamine concentration changes in the caudate-putamen during tonic and phasic firing. J Neurochem (2003) 1.95
Phasic dopamine release evoked by abused substances requires cannabinoid receptor activation. J Neurosci (2007) 1.95
Mesocortical dopamine neurons operate in distinct temporal domains using multimodal signaling. J Neurosci (2005) 1.94
Topoisomerases facilitate transcription of long genes linked to autism. Nature (2013) 1.93
Extinction of cocaine self-administration reveals functionally and temporally distinct dopaminergic signals in the nucleus accumbens. Neuron (2005) 1.90
Correlation of local changes in extracellular oxygen and pH that accompany dopaminergic terminal activity in the rat caudate-putamen. J Neurochem (2003) 1.89
Cocaine increases dopamine release by mobilization of a synapsin-dependent reserve pool. J Neurosci (2006) 1.88
Dynamic gain control of dopamine delivery in freely moving animals. J Neurosci (2004) 1.86
Coordinated accumbal dopamine release and neural activity drive goal-directed behavior. Neuron (2007) 1.84
Developmental switch in the contribution of presynaptic and postsynaptic NMDA receptors to long-term depression. J Neurosci (2007) 1.81
In vivo comparison of norepinephrine and dopamine release in rat brain by simultaneous measurements with fast-scan cyclic voltammetry. J Neurochem (2011) 1.81
Transsynaptic signaling by activity-dependent cleavage of neuroligin-1. Neuron (2012) 1.79
GABA(B) receptor agonists reduce operant ethanol self-administration and enhance ethanol sedation in C57BL/6J mice. Psychopharmacology (Berl) (2004) 1.78
Dynamic changes in accumbens dopamine correlate with learning during intracranial self-stimulation. Proc Natl Acad Sci U S A (2008) 1.77
Elevated extracellular CRF levels in the bed nucleus of the stria terminalis during ethanol withdrawal and reduction by subsequent ethanol intake. Pharmacol Biochem Behav (2002) 1.75
Social and neural determinants of aggressive behavior: pharmacotherapeutic targets at serotonin, dopamine and gamma-aminobutyric acid systems. Psychopharmacology (Berl) (2002) 1.73
Angelman syndrome: insights into genomic imprinting and neurodevelopmental phenotypes. Trends Neurosci (2011) 1.72
Phasic nucleus accumbens dopamine release encodes effort- and delay-related costs. Biol Psychiatry (2010) 1.68
Dopamine detection with fast-scan cyclic voltammetry used with analog background subtraction. Anal Chem (2008) 1.66
The programming of individual differences in defensive responses and reproductive strategies in the rat through variations in maternal care. Neurosci Biobehav Rev (2005) 1.62
Childhood-onset schizophrenia: an open-label study of olanzapine in adolescents. J Am Acad Child Adolesc Psychiatry (1998) 1.59
Carbon microelectrodes with a renewable surface. Anal Chem (2010) 1.56
Neural encoding of cocaine-seeking behavior is coincident with phasic dopamine release in the accumbens core and shell. Eur J Neurosci (2009) 1.56
Functional microcircuitry in the accumbens underlying drug addiction: insights from real-time signaling during behavior. Curr Opin Neurobiol (2004) 1.55
Real-time measurements of phasic changes in extracellular dopamine concentration in freely moving rats by fast-scan cyclic voltammetry. Methods Mol Med (2003) 1.53
Increased amphetamine-induced hyperactivity and reward in mice overexpressing the dopamine transporter. Proc Natl Acad Sci U S A (2008) 1.52
Response times of carbon fiber microelectrodes to dynamic changes in catecholamine concentration. Anal Chem (2002) 1.52
Multivariate concentration determination using principal component regression with residual analysis. Trends Analyt Chem (2009) 1.52
Presynaptic NMDA receptors: newly appreciated roles in cortical synaptic function and plasticity. Neuroscientist (2008) 1.51
The mGluR5 antagonist 6-methyl-2-(phenylethynyl)pyridine decreases ethanol consumption via a protein kinase C epsilon-dependent mechanism. Mol Pharmacol (2004) 1.50
Voltammetric detection of 5-hydroxytryptamine release in the rat brain. Anal Chem (2009) 1.50
The mGluR5 antagonist MPEP decreases operant ethanol self-administration during maintenance and after repeated alcohol deprivations in alcohol-preferring (P) rats. Psychopharmacology (Berl) (2005) 1.49
Frequency of dopamine concentration transients increases in dorsal and ventral striatum of male rats during introduction of conspecifics. J Neurosci (2002) 1.47
Simultaneous dopamine and single-unit recordings reveal accumbens GABAergic responses: implications for intracranial self-stimulation. Proc Natl Acad Sci U S A (2005) 1.44
CRF-1 antagonist and CRF-2 agonist decrease binge-like ethanol drinking in C57BL/6J mice independent of the HPA axis. Neuropsychopharmacology (2010) 1.44
Cue-induced reinstatement of alcohol-seeking behavior is associated with increased ERK1/2 phosphorylation in specific limbic brain regions: blockade by the mGluR5 antagonist MPEP. Neuropharmacology (2008) 1.38
Definition and classification of hyperkinetic movements in childhood. Mov Disord (2010) 1.38
Sources contributing to the average extracellular concentration of dopamine in the nucleus accumbens. J Neurochem (2012) 1.37
Basolateral amygdala modulates terminal dopamine release in the nucleus accumbens and conditioned responding. Biol Psychiatry (2009) 1.36
In vivo voltammetric monitoring of norepinephrine release in the rat ventral bed nucleus of the stria terminalis and anteroventral thalamic nucleus. Eur J Neurosci (2009) 1.35
Cocaine cues drive opposing context-dependent shifts in reward processing and emotional state. Biol Psychiatry (2011) 1.34
NR3A-containing NMDARs promote neurotransmitter release and spike timing-dependent plasticity. Nat Neurosci (2011) 1.33
Downregulation of NR3A-containing NMDARs is required for synapse maturation and memory consolidation. Neuron (2009) 1.31
Maternal influences on the sexual behavior and reproductive success of the female rat. Horm Behav (2008) 1.30
Dopamine release is severely compromised in the R6/2 mouse model of Huntington's disease. J Neurochem (2006) 1.29
Higher sensitivity dopamine measurements with faster-scan cyclic voltammetry. Anal Chem (2011) 1.29
Characterization of local pH changes in brain using fast-scan cyclic voltammetry with carbon microelectrodes. Anal Chem (2010) 1.27
The ratio of NR2A/B NMDA receptor subunits determines the qualities of ocular dominance plasticity in visual cortex. Proc Natl Acad Sci U S A (2009) 1.26
Functional selectivity of dopamine receptor agonists. I. Selective activation of postsynaptic dopamine D2 receptors linked to adenylate cyclase. J Pharmacol Exp Ther (2002) 1.25
Simultaneous decoupled detection of dopamine and oxygen using pyrolyzed carbon microarrays and fast-scan cyclic voltammetry. Anal Chem (2009) 1.23
Metabotropic glutamate receptor 5 activity in the nucleus accumbens is required for the maintenance of ethanol self-administration in a rat genetic model of high alcohol intake. Biol Psychiatry (2009) 1.22
Disparity between tonic and phasic ethanol-induced dopamine increases in the nucleus accumbens of rats. Alcohol Clin Exp Res (2009) 1.22
Pharmacological and anatomical evidence for an interaction between mGluR5- and GABA(A) alpha1-containing receptors in the discriminative stimulus effects of ethanol. Neuropsychopharmacology (2005) 1.21
Amperometry and cyclic voltammetry with carbon fiber microelectrodes at single cells. Curr Protoc Neurosci (2002) 1.19
Activity-induced remodeling of olfactory bulb microcircuits revealed by monosynaptic tracing. PLoS One (2011) 1.19
Abstinence following alcohol drinking produces depression-like behavior and reduced hippocampal neurogenesis in mice. Neuropsychopharmacology (2008) 1.19
Electroosmotic flow and its contribution to iontophoretic delivery. Anal Chem (2008) 1.18
Maternal oral intake mouse model for fetal alcohol spectrum disorders: ocular defects as a measure of effect. Alcohol Clin Exp Res (2006) 1.18
PAP and NT5E inhibit nociceptive neurotransmission by rapidly hydrolyzing nucleotides to adenosine. Mol Pain (2011) 1.18
Nomifensine amplifies subsecond dopamine signals in the ventral striatum of freely-moving rats. J Neurochem (2004) 1.16
Visual deprivation modifies both presynaptic glutamate release and the composition of perisynaptic/extrasynaptic NMDA receptors in adult visual cortex. J Neurosci (2005) 1.16
Regulation of motivation to self-administer ethanol by mGluR5 in alcohol-preferring (P) rats. Alcohol Clin Exp Res (2007) 1.16
Behavioral deficits in an Angelman syndrome model: effects of genetic background and age. Behav Brain Res (2013) 1.15
Paradoxical modulation of short-term facilitation of dopamine release by dopamine autoreceptors. J Neurochem (2007) 1.14
Influence of the NR3A subunit on NMDA receptor functions. Prog Neurobiol (2010) 1.14
Neurochemistry and electroanalytical probes. Curr Opin Chem Biol (2002) 1.14
Fluorinated xerogel-derived microelectrodes for amperometric nitric oxide sensing. Anal Chem (2008) 1.14
Neurosteroids, GABAA receptors, and escalated aggressive behavior. Horm Behav (2003) 1.14
Suppression of heavy drinking and alcohol seeking by a selective ALDH-2 inhibitor. Alcohol Clin Exp Res (2009) 1.13
Microfabricated FSCV-compatible microelectrode array for real-time monitoring of heterogeneous dopamine release. Analyst (2010) 1.13
Maternal loss of Ube3a produces an excitatory/inhibitory imbalance through neuron type-specific synaptic defects. Neuron (2012) 1.12
Microelectrodes for studying neurobiology. Curr Opin Chem Biol (2008) 1.12
Electrochemical Dopamine Detection: Comparing Gold and Carbon Fiber Microelectrodes using Background Subtracted Fast Scan Cyclic Voltammetry. J Electroanal Chem (Lausanne) (2008) 1.12
Simultaneous monitoring of dopamine concentration at spatially different brain locations in vivo. Biosens Bioelectron (2009) 1.12
mGlu5 receptors are involved in the discriminative stimulus effects of self-administered ethanol in rats. Eur J Pharmacol (2006) 1.11
Flexible software platform for fast-scan cyclic voltammetry data acquisition and analysis. Anal Chem (2013) 1.11
Comparison of ethanol locomotor sensitization in adolescent and adult DBA/2J mice. Psychopharmacology (Berl) (2007) 1.09